← Back to Search

Face Tent Ventilation System for Risk Reduction During Pediatric Surgeries

N/A
Waitlist Available
Led By Stephanie Pan, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
children receiving anesthesia-related aerosol generating medical procedures
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 60 minutes
Awards & highlights

Study Summary

This trial will test how well a local exhaust ventilation system (LEVS) works to reduce exposure to infectious and smoke particulates for medical providers during anesthesia-related AGMPs and pediatric surgeries.

Who is the study for?
This trial is for children undergoing anesthesia-related procedures that create aerosols, which are tiny particles that can be inhaled. Children who have tested positive for COVID-19 or show symptoms of the virus cannot participate.Check my eligibility
What is being tested?
The study aims to measure how much medical staff are exposed to infectious and smoke particles during certain pediatric surgeries. It will then test a local exhaust ventilation system (LEVS) to see if it reduces this exposure.See study design
What are the potential side effects?
Since this trial tests a protective device rather than a medication, there aren't direct side effects like with drugs. However, there may be indirect effects related to comfort or visibility while using the LEVS.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is undergoing a procedure that requires anesthesia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 60 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Aerosolized particle concentration in air

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pediatric PatientsExperimental Treatment1 Intervention
Participants undergoing anesthesia-related aerosol generating medical procedures (AGMPs) and pediatric otolaryngologic surgeries will have a local exhaust ventilation system to the exposure seen by the medical providers during the AGMPs and surgeries.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,386 Previous Clinical Trials
17,333,982 Total Patients Enrolled
2 Trials studying Risk Reduction
659 Patients Enrolled for Risk Reduction
Ban C Tsui, MDStudy DirectorStanford University
2 Previous Clinical Trials
152 Total Patients Enrolled
Stephanie Pan, MDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
90 Total Patients Enrolled

Media Library

Risk Reduction Research Study Groups: Pediatric Patients
Risk Reduction Clinical Trial 2023: Disposable oxygen face tent Highlights & Side Effects. Trial Name: NCT04577209 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is eligibility for this trial restricted to individuals younger than 45?

"Eligibility for this study mandates that the patient is between 2 and 18 years of age. In addition, there are 4 trials available to minors and 23 clinical studies available to those over 65."

Answered by AI

Can I participate in this analysis?

"To qualify for this research, patients must be between the ages of 2 and 18 with an established risk reduction. The trial is currently open to 26 participants."

Answered by AI

Is the trial actively enrolling patients at this point in time?

"The trial data found on clinicaltrials.gov discloses that this particular medical study is not presently looking for participants; its initial posting was made on January 1st 2023 and the last update occurred on July 21st 2022. Despite no longer recruiting, there are 28 alternative trials in search of patients at present."

Answered by AI
~17 spots leftby Dec 2024